GE HealthCare Technologies Inc. $GEHC Shares Acquired by Valicenti Advisory Services Inc.

Valicenti Advisory Services Inc. lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,107 shares of the company’s stock after purchasing an additional 12,550 shares during the quarter. GE HealthCare Technologies comprises approximately 1.1% of Valicenti Advisory Services Inc.’s portfolio, making the stock its 26th biggest position. Valicenti Advisory Services Inc.’s holdings in GE HealthCare Technologies were worth $5,115,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Dodge & Cox raised its position in GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after buying an additional 6,982,441 shares during the last quarter. Norges Bank acquired a new position in shares of GE HealthCare Technologies during the second quarter worth about $468,120,000. Holocene Advisors LP raised its holdings in GE HealthCare Technologies by 178.5% during the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock worth $298,306,000 after purchasing an additional 2,581,522 shares in the last quarter. Menora Mivtachim Holdings LTD. acquired a new stake in GE HealthCare Technologies in the second quarter valued at about $80,755,000. Finally, Balyasny Asset Management L.P. purchased a new stake in GE HealthCare Technologies in the 2nd quarter valued at approximately $58,388,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of analyst reports. Citigroup increased their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Jefferies Financial Group upped their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Barclays initiated coverage on GE HealthCare Technologies in a report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price for the company. Morgan Stanley upped their price target on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 30th. Finally, Wells Fargo & Company cut their price target on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a report on Thursday, October 30th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $87.09.

GE HealthCare Technologies Stock Up 0.3%

GEHC opened at $83.61 on Friday. The business’s fifty day moving average is $78.74 and its two-hundred day moving average is $75.82. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The company has a market cap of $38.09 billion, a price-to-earnings ratio of 17.27, a PEG ratio of 3.49 and a beta of 1.10. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The business had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the business posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.